.png)
Point of Care Infectious Disease Market by Type and Application- Global Industry Analysis & Forecast to 2027
Published On : September 2020 Pages : 143 Category: Healthcare IT Report Code : HC0912722
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Point of Care Infectious Disease Market By Type (HIV POC, Clostridium difficile POC, HBV POC,Pneumonia or Streptococcus associated infections, Respiratory syncytial virus (RSV) POC,Other infectious disease POC) and Application (Hospitals, Clinics, Home, Assisted Living Healthcare Facilities, Laboratories, Others) - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Point of Care Infectious Disease Markethas encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Point of Care Infectious Disease testing enable the nucleic acid testing and improvements that make POC molecular diagnostics possible. This alsoinclude the loop-mediated isothermal amplification (LAMP), which allows for the rapid detection of DNA/RNA without the requisite for thermal cycling, and the amplified redox assay,
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global Point of Care Infectious Disease Marketsize market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Alere
- Thermo Fisher Scientific Inc
- F. Hoffmann-La Roche Ltd
- Siemens Healthineers
- BD & Company
- Chembio Diagnostics Inc.
- Trinity Biotech
- Cardinal Health
- Quest Diagnostics Inc.
- Bio-Rad Labs Inc.
- bioMérieux SA
- Sight Diagnostics Ltd.,
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Point of Care Infectious Disease Market, By Product Type, Estimates and Forecast, 2017-2027 ($Million)
o HIV POC
o Clostridium difficile POC
o HBV POC
o Pneumonia or Streptococcus associated infections
o Respiratory syncytial virus (RSV) POC
o Other infectious disease POC
· Point of Care Infectious Disease Market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)
o Hospitals
o Clinics
o Home
o Assisted Living Healthcare Facilities
o Laboratories
o Others
· Point of Care Infectious Disease Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Alere
o Thermo Fisher Scientific Inc
o F. Hoffmann-La Roche Ltd
o Siemens Healthineers
o BD & Company
o Chembio Diagnostics Inc.
o Trinity Biotech
o Cardinal Health
o Quest Diagnostics Inc.
o Bio-Rad Labs Inc.
o bioMérieux SA
o Sight Diagnostics Ltd.,
· Point of Care Infectious Disease Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Point of Care Infectious Disease Market , By Country
o U.S. Point of Care Infectious Disease Market
o Canada Point of Care Infectious Disease Market
o Mexico Point of Care Infectious Disease Market
o Europe
§ Europe Point of Care Infectious Disease Market , By Country
o UK Point of Care Infectious Disease Market
o Germany Point of Care Infectious Disease Market
o France Point of Care Infectious Disease Market
o Russia Point of Care Infectious Disease Market
o Italy Point of Care Infectious Disease Market
o Rest of Europe Point of Care Infectious Disease Market
o Asia-Pacific
§ Asia-Pacific Point of Care Infectious Disease Market , By Country
o China Point of Care Infectious Disease Market
o Japan Point of Care Infectious Disease Market
o South Korea Point of Care Infectious Disease Market
o India Point of Care Infectious Disease Market
o Southeast Asia Point of Care Infectious Disease Market
o Rest of Asia-Pacific Point of Care Infectious Disease Market
o South America
§ South America Point of Care Infectious Disease Market
o Brazil Point of Care Infectious Disease Market
o Argentina Point of Care Infectious Disease Market
o Columbia Point of Care Infectious Disease Market
o Rest of South America Point of Care Infectious Disease Market
o Middle East and Africa
§ Middle East and Africa Point of Care Infectious Disease Market
o Saudi Arabia Point of Care Infectious Disease Market
o UAE Point of Care Infectious Disease Market
o Egypt Point of Care Infectious Disease Market
o Nigeria Point of Care Infectious Disease Market
o South Africa Point of Care Infectious Disease Market
o Rest of MEA Point of Care Infectious Disease Market
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Point Of Care Infectious Disease Market, By Product Type
5.1. Introduction
5.2. Global Point Of Care Infectious Disease Revenue and Market Share by Product Type (2017-2021)
5.2.1. Global Point Of Care Infectious Disease Revenue and Revenue Share by Product Type (2017-2021)
5.3. HIV POC
5.3.1. Global HIV POC Revenue and Growth Rate (2017-2021)
5.4. Clostridium difficile POC
5.4.1. Global Clostridium difficile POC Revenue and Growth Rate (2017-2021)
5.5. HBV POC
5.5.1. Global HBV POC Revenue and Growth Rate (2017-2021)
5.6. Pneumonia or Streptococcus associated infections
5.6.1. Global Pneumonia or Streptococcus associated infections Revenue and Growth Rate (2017-2021)
5.7. Respiratory syncytial virus (RSV) POC
5.7.1. Global Respiratory syncytial virus (RSV) POC Revenue and Growth Rate (2017-2021)
5.8. Other infectious disease POC
5.8.1. Global Other infectious disease POC Revenue and Growth Rate (2017-2021)
6. Point Of Care Infectious Disease Market, By Applications
6.1. Introduction
6.2. Global Point Of Care Infectious Disease Revenue and Market Share by Applications (2017-2021)
6.2.1. Global Point Of Care Infectious Disease Revenue and Revenue Share by Applications (2017-2021)
6.3. Hospitals
6.3.1. Global Hospitals Revenue and Growth Rate (2017-2021)
6.4. Clinics
6.4.1. Global Clinics Revenue and Growth Rate (2017-2021)
6.5. Home
6.5.1. Global Home Revenue and Growth Rate (2017-2021)
6.6. Assisted Living Healthcare Facilities
6.6.1. Global Assisted Living Healthcare Facilities Revenue and Growth Rate (2017-2021)
6.7. Laboratories
6.7.1. Global Laboratories Revenue and Growth Rate (2017-2021)
6.8. Others
6.8.1. Global Others Revenue and Growth Rate (2017-2021)
7. Point Of Care Infectious Disease Market, By Region
7.1. Introduction
7.2. Global Point Of Care Infectious Disease Revenue and Market Share by Regions
7.2.1. Global Point Of Care Infectious Disease Revenue by Regions (2017-2021)
7.3. North America Point Of Care Infectious Disease by Countries
7.3.1. North America Point Of Care Infectious Disease Revenue and Growth Rate (2017-2021)
7.3.2. North America Point Of Care Infectious Disease Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Point Of Care Infectious Disease by Countries
7.4.1. Europe Point Of Care Infectious Disease Revenue and Growth Rate (2017-2021)
7.4.2. Europe Point Of Care Infectious Disease Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Point Of Care Infectious Disease by Countries
7.5.1. Asia-Pacific Point Of Care Infectious Disease Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Point Of Care Infectious Disease Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Point Of Care Infectious Disease by Countries
7.6.1. South America Point Of Care Infectious Disease Revenue and Growth Rate (2017-2021)
7.6.2. South America Point Of Care Infectious Disease Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Point Of Care Infectious Disease by Countries
7.7.1. Middle East and Africa Point Of Care Infectious Disease Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Point Of Care Infectious Disease Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Alere
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Thermo Fisher Scientific Inc
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. F. Hoffmann-La Roche Ltd
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Siemens Healthineers
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. BD & Company
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Chembio Diagnostics Inc.
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Trinity Biotech
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Cardinal Health
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Quest Diagnostics Inc.
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. Bio-Rad Labs Inc.
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
8.11. bioMérieux SA
8.11.1. Business Overview
8.11.2. Service Portfolio
8.11.3. Strategic Developments
8.11.4. Financial Overview
8.12. Sight Diagnostics Ltd.,
8.12.1. Business Overview
8.12.2. Service Portfolio
8.12.3. Strategic Developments
8.12.4. Financial Overview
9. Point Of Care Infectious Disease Market Forecast (2022-2027)
9.1. Global Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Point Of Care Infectious Disease Market Forecast by Regions (2022-2027)
9.2.1. North America Point Of Care Infectious Disease Market Forecast (2022-2027)
9.2.1.1. United States Point Of Care Infectious Disease Market Forecast (2022-2027)
9.2.1.2. Canada Point Of Care Infectious Disease Market Forecast (2022-2027)
9.2.1.3. Mexico Point Of Care Infectious Disease Market Forecast (2022-2027)
9.2.2. Europe Point Of Care Infectious Disease Market Forecast (2022-2027)
9.2.2.1. Germany Point Of Care Infectious Disease Market Forecast (2022-2027)
9.2.2.2. France Point Of Care Infectious Disease Market Forecast (2022-2027)
9.2.2.3. UK Point Of Care Infectious Disease Market Forecast (2022-2027)
9.2.2.4. Russia Point Of Care Infectious Disease Market Forecast (2022-2027)
9.2.2.5. Italy Point Of Care Infectious Disease Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Point Of Care Infectious Disease Market Forecast (2022-2027)
9.2.3. Asia-Pacific Point Of Care Infectious Disease Market Forecast (2022-2027)
9.2.3.1. China Point Of Care Infectious Disease Market Forecast (2022-2027)
9.2.3.2. Japan Point Of Care Infectious Disease Market Forecast (2022-2027)
9.2.3.3. Korea Point Of Care Infectious Disease Market Forecast (2022-2027)
9.2.3.4. India Point Of Care Infectious Disease Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Point Of Care Infectious Disease Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Point Of Care Infectious Disease Market Forecast (2022-2027)
9.2.4. South America Point Of Care Infectious Disease Market Forecast (2022-2027)
9.2.4.1. Brazil Point Of Care Infectious Disease Market Forecast (2022-2027)
9.2.4.2. Argentina Point Of Care Infectious Disease Market Forecast (2022-2027)
9.2.4.3. Columbia Point Of Care Infectious Disease Market Forecast (2022-2027)
9.2.4.4. Rest of South America Point Of Care Infectious Disease Market Forecast (2022-2027)
9.2.5. Middle East and Africa Point Of Care Infectious Disease Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Point Of Care Infectious Disease Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Point Of Care Infectious Disease Market Forecast (2022-2027)
9.2.5.3. Egypt Point Of Care Infectious Disease Market Forecast (2022-2027)
9.2.5.4. Nigeria Point Of Care Infectious Disease Market Forecast (2022-2027)
9.2.5.5. South Africa Point Of Care Infectious Disease Market Forecast (2022-2027)
9.2.5.6. Turkey Point Of Care Infectious Disease Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Point Of Care Infectious Disease Market Forecast (2022-2027)
9.3. Point Of Care Infectious Disease Market Forecast by Product Type (2022-2027)
9.3.1. Point Of Care Infectious Disease Forecast by Product Type (2022-2027)
9.3.2. Point Of Care Infectious Disease Market Share Forecast by Product Type (2022-2027)
9.4. Point Of Care Infectious Disease Market Forecast by Applications (2022-2027)
9.4.1. Point Of Care Infectious Disease Forecast by Applications (2022-2027)
9.4.2. Point Of Care Infectious Disease Market Share Forecast by Applications (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Point Of Care Infectious Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Point Of Care Infectious Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Point Of Care Infectious Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Point Of Care Infectious Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Point Of Care Infectious Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Point Of Care Infectious Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Point Of Care Infectious Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Point Of Care Infectious Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Point Of Care Infectious Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Point Of Care Infectious Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Point Of Care Infectious Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Point Of Care Infectious Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Point Of Care Infectious Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Point Of Care Infectious Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Point Of Care Infectious Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Point Of Care Infectious Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Point Of Care Infectious Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Point Of Care Infectious Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Point Of Care Infectious Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Point Of Care Infectious Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Point Of Care Infectious Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Point Of Care Infectious Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Point Of Care Infectious Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Point Of Care Infectious Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Point Of Care Infectious Disease Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Point Of Care Infectious Disease Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Point Of Care Infectious Disease Revenue and Revenue Share by Product Type (2017-2019)
Figure Global HIV POC Revenue and Growth Rate (2017-2019)
Figure Global Clostridium difficile POC Revenue and Growth Rate (2017-2019)
Figure Global HBV POC Revenue and Growth Rate (2017-2019)
Figure Global Pneumonia or Streptococcus associated infections Revenue and Growth Rate (2017-2019)
Figure Global Respiratory syncytial virus (RSV) POC Revenue and Growth Rate (2017-2019)
Figure Global Other infectious disease POC Revenue and Growth Rate (2017-2019)
Table Global Point Of Care Infectious Disease Revenue and Revenue Share by Applications (2017-2019)
Figure Global Hospitals Revenue and Growth Rate (2017-2019)
Figure Global Clinics Revenue and Growth Rate (2017-2019)
Figure Global Home Revenue and Growth Rate (2017-2019)
Figure Global Assisted Living Healthcare Facilities Revenue and Growth Rate (2017-2019)
Figure Global Laboratories Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Point Of Care Infectious Disease Revenue by Regions (2017-2019)
Figure North America Point Of Care Infectious Disease Growth Rate (2017-2019)
Figure North America Point Of Care Infectious Disease Revenue and Growth Rate (2017-2019)
Figure North America Point Of Care Infectious Disease by Countries (2017-2019)
Figure North America Point Of Care Infectious Disease Revenue (Million USD) by Countries (2017-2019)
Figure United States Point Of Care Infectious Disease Growth Rate (2017-2019)
Figure United States Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Point Of Care Infectious Disease Growth Rate (2017-2019)
Figure Canada Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Point Of Care Infectious Disease Growth Rate (2017-2019)
Figure Mexico Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Point Of Care Infectious Disease Growth Rate (2017-2019)
Figure Europe Point Of Care Infectious Disease Revenue and Growth Rate (2017-2019)
Figure Europe Point Of Care Infectious Disease by Countries (2017-2019)
Figure Europe Point Of Care Infectious Disease Revenue (Million USD) by Countries (2017-2019)
Figure Germany Point Of Care Infectious Disease Growth Rate (2017-2019)
Figure Germany Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Point Of Care Infectious Disease Growth Rate (2017-2019)
Figure France Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Point Of Care Infectious Disease Growth Rate (2017-2019)
Figure UK Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Point Of Care Infectious Disease Growth Rate (2017-2019)
Figure Russia Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Point Of Care Infectious Disease Growth Rate (2017-2019)
Figure Italy Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Point Of Care Infectious Disease Growth Rate (2017-2019)
Figure Rest of Europe Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Point Of Care Infectious Disease Growth Rate (2017-2019)
Figure Asia-Pacific Point Of Care Infectious Disease Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Point Of Care Infectious Disease by Countries (2017-2019)
Figure Asia-Pacific Point Of Care Infectious Disease Revenue (Million USD) by Countries (2017-2019)
Figure China Point Of Care Infectious Disease Growth Rate (2017-2019)
Figure China Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Point Of Care Infectious Disease Growth Rate (2017-2019)
Figure Japan Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Point Of Care Infectious Disease Growth Rate (2017-2019)
Figure Korea Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Point Of Care Infectious Disease Growth Rate (2017-2019)
Figure India Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Point Of Care Infectious Disease Growth Rate (2017-2019)
Figure Southeast Asia Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Point Of Care Infectious Disease Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Point Of Care Infectious Disease Growth Rate (2017-2019)
Figure South America Point Of Care Infectious Disease Revenue and Growth Rate (2017-2019)
Figure South America Point Of Care Infectious Disease by Countries (2017-2019)
Figure South America Point Of Care Infectious Disease Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Point Of Care Infectious Disease Growth Rate (2017-2019)
Figure Brazil Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Point Of Care Infectious Disease Growth Rate (2017-2019)
Figure Argentina Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Point Of Care Infectious Disease Growth Rate (2017-2019)
Figure Columbia Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Point Of Care Infectious Disease Growth Rate (2017-2019)
Figure Rest of South America Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Point Of Care Infectious Disease Growth Rate (2017-2019)
Figure Middle East and Africa Point Of Care Infectious Disease Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Point Of Care Infectious Disease by Countries (2017-2019)
Figure Middle East and Africa Point Of Care Infectious Disease Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Point Of Care Infectious Disease Growth Rate (2017-2019)
Figure Saudi Arabia Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Point Of Care Infectious Disease Growth Rate (2017-2019)
Figure United Arab Emirates Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Point Of Care Infectious Disease Growth Rate (2017-2019)
Figure Egypt Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Point Of Care Infectious Disease Growth Rate (2017-2019)
Figure Nigeria Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Point Of Care Infectious Disease Growth Rate (2017-2019)
Figure South Africa Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Point Of Care Infectious Disease Growth Rate (2017-2019)
Figure Turkey Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Point Of Care Infectious Disease Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2017-2019)
Table Alere Point Of Care Infectious Disease Financial Overview
Table Thermo Fisher Scientific Inc Point Of Care Infectious Disease Financial Overview
Table F. Hoffmann-La Roche Ltd Point Of Care Infectious Disease Financial Overview
Table Siemens Healthineers Point Of Care Infectious Disease Financial Overview
Table BD & Company Point Of Care Infectious Disease Financial Overview
Table Chembio Diagnostics Inc. Point Of Care Infectious Disease Financial Overview
Table Trinity Biotech Point Of Care Infectious Disease Financial Overview
Table Cardinal Health Point Of Care Infectious Disease Financial Overview
Table Quest Diagnostics Inc. Point Of Care Infectious Disease Financial Overview
Table Bio-Rad Labs Inc. Point Of Care Infectious Disease Financial Overview
Table bioMérieux SA Point Of Care Infectious Disease Financial Overview
Table Sight Diagnostics Ltd., Point Of Care Infectious Disease Financial Overview
Figure Global Point Of Care Infectious Disease Revenue (Millions USD) and Growth Rate (2019-2027)
Table Point Of Care Infectious Disease Market Forecast by Regions (2019-2027)
Figure North America Point Of Care Infectious Disease Market Forecast (2019-2027)
Figure United States Point Of Care Infectious Disease Market Forecast (2019-2027)
Figure Canada Point Of Care Infectious Disease Market Forecast (2019-2027)
Figure Mexico Point Of Care Infectious Disease Market Forecast (2019-2027)
Figure Europe Point Of Care Infectious Disease Market Forecast (2019-2027)
Figure Germany Point Of Care Infectious Disease Market Forecast (2019-2027)
Figure France Point Of Care Infectious Disease Market Forecast (2019-2027)
Figure UK Point Of Care Infectious Disease Market Forecast (2019-2027)
Figure Russia Point Of Care Infectious Disease Market Forecast (2019-2027)
Figure Italy Point Of Care Infectious Disease Market Forecast (2019-2027)
Figure Rest of Europe Point Of Care Infectious Disease Market Forecast (2019-2027)
Figure Asia-Pacific Point Of Care Infectious Disease Market Forecast (2019-2027)
Figure China Point Of Care Infectious Disease Market Forecast (2019-2027)
Figure Japan Point Of Care Infectious Disease Market Forecast (2019-2027)
Figure Korea Point Of Care Infectious Disease Market Forecast (2019-2027)
Figure India Point Of Care Infectious Disease Market Forecast (2019-2027)
Figure Southeast Asia Point Of Care Infectious Disease Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Point Of Care Infectious Disease Market Forecast (2019-2027)
Figure South America Point Of Care Infectious Disease Market Forecast (2019-2027)
Figure Brazil Point Of Care Infectious Disease Market Forecast (2019-2027)
Figure Argentina Point Of Care Infectious Disease Market Forecast (2019-2027)
Figure Columbia Point Of Care Infectious Disease Market Forecast (2019-2027)
Figure Rest of South America Point Of Care Infectious Disease Market Forecast (2019-2027)
Figure Middle East and Africa Point Of Care Infectious Disease Market Forecast (2019-2027)
Figure Saudi Arabia Point Of Care Infectious Disease Market Forecast (2019-2027)
Figure United Arab Emirates Point Of Care Infectious Disease Market Forecast (2019-2027)
Figure Egypt Point Of Care Infectious Disease Market Forecast (2019-2027)
Figure Nigeria Point Of Care Infectious Disease Market Forecast (2019-2027)
Figure South Africa Point Of Care Infectious Disease Market Forecast (2019-2027)
Figure Turkey Point Of Care Infectious Disease Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Point Of Care Infectious Disease Market Forecast (2019-2027)
Figure Global Point Of Care Infectious Disease Forecast by Product Type (2019-2027)
Figure Global Point Of Care Infectious Disease Market Share Forecast by Product Type (2019-2027)
Figure Global Point Of Care Infectious Disease Forecast by Product Type (2019-2027)
Figure Global Point Of Care Infectious Disease Forecast by Applications (2019-2027)
Figure Global Point Of Care Infectious Disease Market Share Forecast by Applications (2019-2027)
Figure Global Point Of Care Infectious Disease Forecast by Applications (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|